Phares AG, located in Basel, Switzerland provides a range of services and products to develop dosage forms for insoluble compounds. Phares 360 services (www.Phares360.com) include pharmaceutical profiling for lead selection (Survey), rapid solutions for tox testing (Speed) and developing clinical formulations with enhanced bioavailability (Icebreaker). These services use a variety of specific technologies to improve the solubility and dissolution of poorly soluble compounds by selecting the appropriate physical state; Solubilized, Amorphous and Crystalline. Additionally, Phares sells products to help companies develop their compounds in-house. These are sold exclusively on www.ePhares.com and include a standardized powder to prepare FeSSIF and FaSSIF instantly (SIF Powder) and a liposome solubilization vehicle suitable for parenteral and oral administration (Liposome). Our mission is to help our clients reach the clinic faster by accelerating the development time of their compound.